139 related articles for article (PubMed ID: 25174794)
1. Unresectable cardiac pseudoneoplasms causing ventricular tachycardia.
Malaczynska-Rajpold K; Blaszyk K; Kurzawa P; Pyda M; Wachowiak-Baszynska H; Mularek-Kubzdela T; Grajek S
Cardiovasc Pathol; 2014; 23(6):372-5. PubMed ID: 25174794
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
[TBL] [Abstract][Full Text] [Related]
3. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].
Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F
Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137
[TBL] [Abstract][Full Text] [Related]
4. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
5. Identification and management of ventricular tachycardia.
Naik N; Talwar KK
J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
7. [Current management of patients with ventricular tachycardia].
Puljević D; Buljević B; Milicić D
Lijec Vjesn; 2001; 123(7-8):191-200. PubMed ID: 11729615
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
[TBL] [Abstract][Full Text] [Related]
9. [Implantation of a transvenous defibrillation system in isolated persistent left superior vena cava].
Peters W; Krein A; Kowallik P; Wittenberg G; Meesmann M
Dtsch Med Wochenschr; 1997 Mar; 122(12):366-70. PubMed ID: 9118791
[TBL] [Abstract][Full Text] [Related]
10. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
11. Ventricular tachycardia: beginning and ending fate of a benign invasive cardiac lipoma.
Vriz O; Ahmed MM; Kharabsheha S; Aladmawi M; Alamro B; AlSomali A; Fawzy N; ALsanei A; Echahidi NM
Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32672428
[TBL] [Abstract][Full Text] [Related]
12. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
14. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade.
Kantharia BK; Patel JA; Nagra BS; Ledley GS
Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
16. Cardioverter-defibrillator implantation to treat cardiac fibroma-induced ventricular tachycardia in a 70-year-old woman.
Hakim FA; Pandit A; Mookadam F; Mamby S
Tex Heart Inst J; 2014 Jun; 41(3):329-31. PubMed ID: 24955056
[TBL] [Abstract][Full Text] [Related]
17. Ventricular tachycardia associated with radiation-induced cardiac sarcoma.
Beaty EH; Ballany W; Trohman RG; Madias C
Tex Heart Inst J; 2014 Dec; 41(6):620-5. PubMed ID: 25593527
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
20. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
Strohmer B; Schernthaner C; Pichler M
J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
